Teaching hospital Program year 2025 Source: CMS Open Payments

UT MD Anderson Cancer Center

CCN 450076 CMS hospital 16905

Open in the dashboard

General payments

$372,832,993

2,155 payments

Research payments

$1,888,295,138

45,087 payments

Through program year 2025, UT MD Anderson Cancer Center is reported as receiving $372,832,993 in general payments and $1,888,295,138 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows

General

’19 ’20 ’21 ’22 ’23 ’24 ’25

Peak $317.6M

Research

’19 ’20 ’21 ’22 ’23 ’24 ’25

Peak $292.2M

Year	Kind	Amount	Payments
2025	General	$5,717,614	288
2025	Research	$286,166,144	8,456
2024	General	$9,441,579	292
2024	Research	$278,637,340	6,486
2023	General	$8,007,423	270
2023	Research	$277,914,896	5,373
2022	General	$13,108,941	224
2022	Research	$292,163,335	6,346
2021	General	$6,622,757	202
2021	Research	$282,765,390	5,695
2020	General	$12,380,536	301
2020	Research	$229,767,705	6,498
2019	General	$317,554,143	578
2019	Research	$240,880,328	6,233

Breakdown

Who paid General payments · program years 2019–2025

Takeda Pharmaceuticals U.S.A., Inc. $301,436,514 34 payments
Ge Healthcare $7,176,160 28 payments
Ipsen Bioscience Inc $6,331,780 10 payments
Siemens Medical Solutions USA, Inc. $6,196,247 138 payments
Abbott Laboratories $6,097,207 32 payments
Philips Electronics North America Corporation $5,758,354 13 payments
Biogen, Inc. $3,792,332 5 payments
Genentech, Inc. $2,552,113 36 payments
UIH America, Inc. $2,490,080 18 payments
Novartis Pharmaceuticals Corporation $2,193,016 32 payments
Other $28,809,190 1,809 payments

What the payments were for General payments · program years 2019–2025

Royalty or License $342,811,185 552 payments
Grant $13,381,179 392 payments
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,805,105 204 payments
Current or prospective ownership or investment interest $3,276,256 4 payments
Space rental or facility fees (teaching hospital only) $2,796,057 585 payments
Consulting Fee $1,779,238 25 payments
Long term medical supply or device loan $1,391,837 121 payments
Education $986,773 89 payments
Gift $221,394 56 payments
Debt forgiveness $168,925 51 payments
Other $215,045 76 payments

Products named General payments · program years 2019–2025

Supera peripheral stent system $3,893,574 8 payments
Skyclarys $3,792,332 5 payments
uMI $1,405,000 12 payments
Supera $1,322,142 6 payments
Oncology $1,162,500 1 payment
(8881) Oncology Genomics $1,162,500 2 payments
(1542) Royalties $1,145,562 2 payments
(9539) Lung Cancer Orchestrator $1,115,453 5 payments
Other $1,106,749 1 payment
Pet-Ct $750,000 1 payment
Other $14,254,711 1,505 payments

A payment can name more than one product, so these amounts overlap.

Records

2,155 general · 45,087 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.